Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation

被引:108
作者
Clouston, AD
Jonsson, JR
Purdie, DM
Macdonald, GA
Pandeya, N
Shorthouse, C
Powell, EE
机构
[1] Univ Queensland, Dept Pathol, Mayne Med Sch, Brisbane, Qld 4006, Australia
[2] Univ Queensland, Dept Surg, Brisbane, Qld 4006, Australia
[3] Queensland Inst Med Res, Epidemiol & Populat Hlth Unit, Brisbane, Qld 4006, Australia
[4] Univ Queensland, Dept Med, Brisbane, Qld 4006, Australia
[5] Queensland Inst Med Res, Clin Sci Unit, Brisbane, Qld 4006, Australia
[6] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia
关键词
obesity; body mass index;
D O I
10.1016/S0168-8278(00)00096-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Steatosis is a frequent histological finding in chronic hepatitis C and is associated with increased hepatic fibrosis. Methods: We studied 80 patients with untreated chronic hepatitis C to determine whether steatosis contributes to fibrosis through a steatohepatitis-like pathway. Results: Fine sinusoidal and/or central vein fibrosis was present in 52 patients (65%), This was typically located in acinar zone 3 and had a chicken-wire appearance similar to that seen in steatohepatitis. A statistically significant relationship was found between subsinusoidal fibrosis and age (r(s) = 0,33, P = 0.003) and grade of steatosis (r(s) = 0.35, P = 0.001). Mean body mass index was higher in patients with focal (28.4 +/- 4.7 kg/m(2)) or extensive (29.6 +/- 5.9 kg/m(2)) subsinusoidal fibrosis than in those patients with no subsinusoidal fibrosis (25.5 +/- 3.7 kg/m(2)). The extent of or-smooth muscle actin staining (as a marker of stellate cell activation) correlated with the degree of portal inflammation and the stage of portal fibrosis, but not with the grade of hepatic steatosis. Conclusions: These findings suggest that in hepatitis C infection, host factors, particularly adiposity, contribute to both steatosis and acinar fibrosis.The implication of these observations is that weight reduction may provide an important therapeutic strategy for patients with chronic hepatitis C. (C) 2001 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:314 / 320
页数:7
相关论文
共 31 条
  • [1] Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients
    Adinolfi, LE
    Utili, R
    Ruggiero, G
    [J]. HEPATOLOGY, 1999, 30 (06) : 1530 - 1530
  • [2] BEDOSSA P, 1994, HEPATOLOGY, V19, P1262, DOI 10.1016/0270-9139(94)90876-1
  • [3] Burt AD, 1998, SEMIN DIAGN PATHOL, V15, P246
  • [4] CHEVALLIER M, 1994, HEPATOLOGY, V20, P349, DOI 10.1002/hep.1840200213
  • [5] Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis - A pilot study
    Cortez-Pinto, H
    Chatham, J
    Chacko, VP
    Arnold, C
    Rashid, A
    Diehl, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17): : 1659 - 1664
  • [6] Host- and disease-specific factors affecting steatosis in chronic hepatitis C
    Czaja, AJ
    Carpenter, HA
    Santrach, PJ
    Moore, SB
    [J]. JOURNAL OF HEPATOLOGY, 1998, 29 (02) : 198 - 206
  • [7] Steatohepatitis: A tale of two "hits"?
    Day, CP
    James, OFW
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : 842 - 845
  • [8] Nonalcoholic steatohepatitis
    Diehl, AM
    [J]. SEMINARS IN LIVER DISEASE, 1999, 19 (02) : 221 - 229
  • [9] FELDMANN G, 1995, J HEPATOL, V22, P49
  • [10] Liver steatosis and chronic hepatitis C: A spurious association?
    Fiore, G
    Fera, G
    Napoli, N
    Vella, F
    Schiraldi, O
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (02) : 125 - 129